Moreover, TGFβ1 can also repress the expression of TGFBR3 in HCC cell lines, resulting in subsequent activation of the SMAD2 and AKT pathways and enhanced migratory and invasive cellular capacity [133]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.